These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 34378210)

  • 1. Retrospective analysis of safety and outcomes of rituximab for myasthenia gravis in patients ≥65 years old.
    Doughty CT; Suh J; David WS; Amato AA; Guidon AC
    Muscle Nerve; 2021 Dec; 64(6):651-656. PubMed ID: 34378210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Efficacy and Safety of Low-Dose Rituximab in Patients with Refractory Myasthenia Gravis.
    Ren J; Wang J; Liu R; Jin Y; Guo J; Yao Y; Luo J; Hao H; Gao F
    Eur Neurol; 2023; 86(6):387-394. PubMed ID: 37778340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistant myasthenia gravis and rituximab: A monocentric retrospective study of 28 patients.
    Afanasiev V; Demeret S; Bolgert F; Eymard B; Laforêt P; Benveniste O
    Neuromuscul Disord; 2017 Mar; 27(3):251-258. PubMed ID: 28082209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of rituximab in myasthenia gravis: a French multicentre real-life study.
    Dos Santos A; Noury JB; Genestet S; Nadaj-Pakleza A; Cassereau J; Baron C; Videt D; Michel L; Pereon Y; Wiertlewski S; Magot A
    Eur J Neurol; 2020 Nov; 27(11):2277-2285. PubMed ID: 32526053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab in late-onset myasthenia gravis is safe and effective.
    Sahai SK; Maghzi AH; Lewis RA
    Muscle Nerve; 2020 Sep; 62(3):377-380. PubMed ID: 32239711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of different dosages of rituximab for refractory generalized AChR myasthenia gravis: A meta-analysis.
    Li T; Zhang GQ; Li Y; Dong SA; Wang N; Yi M; Qi Y; Zhai H; Yang L; Shi FD; Yang CS
    J Clin Neurosci; 2021 Mar; 85():6-12. PubMed ID: 33581791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab as treatment for anti-MuSK myasthenia gravis: Multicenter blinded prospective review.
    Hehir MK; Hobson-Webb LD; Benatar M; Barnett C; Silvestri NJ; Howard JF; Howard D; Visser A; Crum BA; Nowak R; Beekman R; Kumar A; Ruzhansky K; Chen IA; Pulley MT; LaBoy SM; Fellman MA; Greene SM; Pasnoor M; Burns TM
    Neurology; 2017 Sep; 89(10):1069-1077. PubMed ID: 28801338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison Between Rituximab Treatment for New-Onset Generalized Myasthenia Gravis and Refractory Generalized Myasthenia Gravis.
    Brauner S; Eriksson-Dufva A; Hietala MA; Frisell T; Press R; Piehl F
    JAMA Neurol; 2020 Aug; 77(8):974-981. PubMed ID: 32364568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab in Myasthenia Gravis- Experience from a Low- and Middle-Income Country (LMIC) Setting.
    Shivaram S; Nagappa M; Varghese N; Seshagiri DV; Duble S; Siddappa SA; Hesarur N; Sinha S; Taly AB
    Neurol India; 2022; 70(5):1931-1941. PubMed ID: 36352590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab as induction therapy in refractory myasthenia gravis: 18 month follow-up study.
    Singh N; Goyal V
    J Neurol; 2019 Jul; 266(7):1596-1600. PubMed ID: 30919039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab Therapy in the Treatment of Juvenile Myasthenia Gravis: The French Experience.
    Molimard A; Gitiaux C; Barnerias C; Audic F; Isapof A; Walther-Louvier U; Cances C; Espil-Taris C; Davion JB; Quijano-Roy S; Grisel C; Chabrol B; Desguerre I
    Neurology; 2022 Jun; 98(23):e2368-e2376. PubMed ID: 35314497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab in myasthenia gravis: efficacy, associated infections and risk of induced hypogammaglobulinemia.
    Caballero-Ávila M; Álvarez-Velasco R; Moga E; Rojas-Garcia R; Turon-Sans J; Querol L; Olivé M; Reyes-Leiva D; Illa I; Gallardo E; Cortés-Vicente E
    Neuromuscul Disord; 2022 Aug; 32(8):664-671. PubMed ID: 35811274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
    Maddison P; McConville J; Farrugia ME; Davies N; Rose M; Norwood F; Jungbluth H; Robb S; Hilton-Jones D
    J Neurol Neurosurg Psychiatry; 2011 Jun; 82(6):671-3. PubMed ID: 20392977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Rituximab in Refractory Generalized anti-AChR Myasthenia Gravis.
    Landon-Cardinal O; Friedman D; Guiguet M; Laforêt P; Heming N; Salort-Campana E; Jouen F; Allenbach Y; Boyer O; Chatenoud L; Eymard B; Sharshar T; Benveniste O
    J Neuromuscul Dis; 2018; 5(2):241-249. PubMed ID: 29865089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab as Adjunct Maintenance Therapy for Refractory Juvenile Myasthenia Gravis.
    Zingariello CD; Elder ME; Kang PB
    Pediatr Neurol; 2020 Oct; 111():40-43. PubMed ID: 32951658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and outcomes of eculizumab for acetylcholine receptor-positive generalized myasthenia gravis in clinical practice.
    Suh J; Clarke V; Amato AA; Guidon AC
    Muscle Nerve; 2022 Sep; 66(3):348-353. PubMed ID: 35684980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential response to rituximab in anti-AChR and anti-MuSK positive myasthenia gravis patients: a single-center retrospective study.
    Litchman T; Roy B; Kumar A; Sharma A; Njike V; Nowak RJ
    J Neurol Sci; 2020 Apr; 411():116690. PubMed ID: 32028072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stopping oral steroid-sparing agents at initiation of rituximab in myasthenia gravis.
    Roda RH; Doherty L; Corse AM
    Neuromuscul Disord; 2019 Jul; 29(7):554-561. PubMed ID: 31296355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promising efficacy of Low-Dose rituximab in Muscle specific kinase antibody positive Myasthenia Gravis.
    Yang X; Zhang W; Chang X; Li Z; Du R; Guo J
    Neurosci Lett; 2024 Jan; 818():137561. PubMed ID: 37984485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab treatment of myasthenia gravis: A systematic review.
    Tandan R; Hehir MK; Waheed W; Howard DB
    Muscle Nerve; 2017 Aug; 56(2):185-196. PubMed ID: 28164324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.